|
Rossari Biotech Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
2806.42 Cr.
|
P/BV
|
2.19
|
Book Value (Rs.)
|
231.78
|
|
52 Week High/Low (Rs.)
|
766/375
|
FV/ML
|
2/1
|
P/E(X)
|
18.81
|
|
Bookclosure
|
20/06/2025
|
EPS (Rs.)
|
26.94
|
Div Yield (%)
|
0.10
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 200.61 | 185.19 | 177.62 | 144.22 | 136.28 |
| | | | | | |
| Net CashFlow From Operating Activities | 65.07 | 137.44 | 43.26 | 152.39 | 29.36 |
| Net Cash Used In Investing Activities | -219.48 | -183.70 | -103.21 | -180.89 | -298.88 |
| Net Cash Used From Financing Activities | 186.32 | 64.90 | 16.19 | 60.86 | 291.79 |
| Foreign Exchange Gains / Losses | -0.80 | 0.38 | -0.25 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 31.11 | 19.03 | -44.03 | 32.36 | 22.27 |
| Cash And Cash Equivalents Begin of Year | 44.20 | 25.17 | 69.20 | 37.48 | 15.21 |
| Cash And Cash Equivalents End Of Year | 75.31 | 44.20 | 25.17 | 69.83 | 37.48 |